Literature DB >> 27354359

Core Concept: Basket trial approach capitalizes on the molecular mechanisms of tumors.

Stephen Ornes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27354359      PMCID： PMC4932997          DOI： 10.1073/pnas.1608277113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  ASCO and NCI Launch Largest Precision Medicine Trials Using Real-World Evidence.

Authors:  Audrey Andrews
Journal:  Am Health Drug Benefits       Date:  2015-08

2.  News feature: Capturing cancer's complexity.

Authors:  Sarah C P Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-14       Impact factor: 11.205

3.  Basket trials and the evolution of clinical trial design in an era of genomic medicine.

Authors:  Amanda J Redig; Pasi A Jänne
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

Review 4.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

5.  Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

Authors:  David M Hyman; Igor Puzanov; Vivek Subbiah; Jason E Faris; Ian Chau; Jean-Yves Blay; Jürgen Wolf; Noopur S Raje; Eli L Diamond; Antoine Hollebecque; Radj Gervais; Maria Elena Elez-Fernandez; Antoine Italiano; Ralf-Dieter Hofheinz; Manuel Hidalgo; Emily Chan; Martin Schuler; Susan Frances Lasserre; Martina Makrutzki; Florin Sirzen; Maria Luisa Veronese; Josep Tabernero; José Baselga
Journal:  N Engl J Med       Date:  2015-08-20       Impact factor: 91.245
  5 in total
  8 in total

1.  Feedback analysis identifies a combination target for overcoming adaptive resistance to targeted cancer therapy.

Authors:  Sang-Min Park; Chae Young Hwang; Jihye Choi; Chang Young Joung; Kwang-Hyun Cho
Journal:  Oncogene       Date:  2020-03-10       Impact factor: 9.867

2.  A Bayesian basket trial design using a calibrated Bayesian hierarchical model.

Authors:  Yiyi Chu; Ying Yuan
Journal:  Clin Trials       Date:  2018-03-02       Impact factor: 2.486

3.  A Phase I-II Basket Trial Design to Optimize Dose-Schedule Regimes Based on Delayed Outcomes.

Authors:  Ruitao Lin; Peter F Thall; Ying Yuan
Journal:  Bayesian Anal       Date:  2020-03-28       Impact factor: 3.728

4.  Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.

Authors:  Ville Kytola; Umit Topaloglu; Lance D Miller; Rhonda L Bitting; Michael M Goodman; Ralph B D Agostino; Rodwige J Desnoyers; Carol Albright; George Yacoub; Shadi A Qasem; Barry DeYoung; Vesteinn Thorsson; Ilya Shmulevich; Meng Yang; Anastasia Shcherban; Matthew Pagni; Liang Liu; Matti Nykter; Kexin Chen; Gregory A Hawkins; Stefan C Grant; W Jeffrey Petty; Angela Tatiana Alistar; Edward A Levine; Edgar D Staren; Carl D Langefeld; Vincent Miller; Gaurav Singal; Robin M Petro; Mac Robinson; William Blackstock; Bayard L Powell; Lynne I Wagner; Kristie L Foley; Edward Abraham; Boris Pasche; Wei Zhang
Journal:  Theranostics       Date:  2017-07-12       Impact factor: 11.556

5.  Reporting of master protocols towards a standardized approach: A systematic review.

Authors:  Ellie G Siden; Jay Jh Park; Michael J Zoratti; Louis Dron; Ofir Harari; Kristian Thorlund; Edward J Mills
Journal:  Contemp Clin Trials Commun       Date:  2019-07-04

Review 6.  An overview of precision oncology basket and umbrella trials for clinicians.

Authors:  Jay J H Park; Grace Hsu; Ellie G Siden; Kristian Thorlund; Edward J Mills
Journal:  CA Cancer J Clin       Date:  2020-02-07       Impact factor: 508.702

Review 7.  Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance.

Authors:  Olalekan Lee Aiyegbusi; Lavinia Ferrante di Ruffano; Ameeta Retzer; Philip N Newsome; Christopher D Buckley; Melanie J Calvert
Journal:  Trials       Date:  2022-01-15       Impact factor: 2.279

8.  Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability.

Authors:  Cornelia Jäkel; Frank Bergmann; Reka Toth; Yassen Assenov; Daniel van der Duin; Oliver Strobel; Thomas Hank; Günter Klöppel; Craig Dorrell; Markus Grompe; Joshua Moss; Yuval Dor; Peter Schirmacher; Christoph Plass; Odilia Popanda; Peter Schmezer
Journal:  Nat Commun       Date:  2017-11-06       Impact factor: 14.919
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.